CALCIUM CHLORIDE- calcium chloride injection injection, solution

国家: 美国

语言: 英文

来源: NLM (National Library of Medicine)

现在购买

产品特点 产品特点 (SPC)
07-06-2023

有效成分:

CALCIUM CHLORIDE (UNII: M4I0D6VV5M) (CALCIUM CATION - UNII:2M83C4R6ZB, CHLORIDE ION - UNII:Q32ZN48698)

可用日期:

Medefil, Inc.

给药途径:

INTRAVENOUS

处方类型:

PRESCRIPTION DRUG

疗效迹象:

10% Calcium Chloride Injection, USP is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels. Safety and effectiveness are based on similar clinical conditions in children and adults. An evaluation of current literature revealed no clinical experience identifying differences in response between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. None known.

產品總結:

10% Cacliumn Chloride Injection, USP is supplied omn single-dose containers as follows: NDC 64253-900-91 10 mL Single-dose prefilled syringes, individually pouched, in a carton of 10s 1000 mg/10 mL (100 mg/mL) NDC 64253-900-30 10 mL fill in 12 mL Syringe Single-dose prefilled syringes, individually pouched NDC 64253-900-36 10 mL Single-dose prefilled syringes, individually pouched, in a carton of 60s 1000 mg/10 mL (100 mg/mL) NDC 64253-900-30 10 mL fill in 12 mL Syringe Single-dose prefilled syringes, individually pouched Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]. Do not freeze.

授权状态:

Abbreviated New Drug Application

产品特点

                                CALCIUM CHLORIDE- CALCIUM CHLORIDE INJECTION INJECTION, SOLUTION
MEDEFIL, INC.
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE 10%
CALCIUM CHLORIDE
INJECTION, USP SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING
INFORMATION FOR 10% CALCIUM
CHLORIDE INJECTION, USP.
10% CALCIUM CHLORIDE INJECTION, USP FOR INTRAVENOUS INJECTION
INITIAL U.S. APPROVAL: 2019
INDICATIONS AND USAGE
(3)
10% Calcium Chloride Injection, USP is indicated for the treatment of
hypocalcemia in those conditions
requiring a prompt increase in plasma calcium levels. (3)
CONTRAINDICATIONS
Calcium chloride is contraindicated for cardiac resuscitation in the
presence of ventricular fibrillation or in
patients with the risk of existing digitalis toxicity. (4)
Calcium chloride is not recommended in the treatment of asystole and
electromechanical dissociation. (4)
ADVERSE REACTIONS
Rapid injection may cause the patient to complain of tingling
sensations, a calcium taste, a sense of
oppression or "heat wave".
Injections of calcium chloride are accompanied by peripheral
vasodilatation as well as a local "burning"
sensation and there may be a moderate fall in blood pressure.
Should perivascular infiltration occur, I.V. administration at that
site should be discontinued at once. Local
infiltration of the affected area with 1% procaine hydrochloride, to
which hyaluronidase may be added, will
often reduce venospasm and dilute the calcium remaining in the tissues
locally. Local application of heat
may also be helpful.
To report SUSPECTED ADVERSE REACTIONS, contact Medefil, Inc., at
1-630-682-4600 or
www.medefilinc.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
DOSAGE AND ADMINISTRATION
10% Calcium Chloride Injection, USP is administered only by slow
intravenous injection (not to exceed 1
mL/min), preferably in a central or deep vein. (14)
The usual precautions for intravenous therapy should be observed. If
time permits, the solution should be
warmed to body temperature. The injection should 
                                
                                阅读完整的文件
                                
                            

搜索与此产品相关的警报